from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2292c/-

LFCtreatmentdescriptionclass of inhibitor

-0.585

Amikacinug/mL Amikacintranslation

-1.095

Cap5-10ug/mL Capreomycintranslation

0.477

Rox10-50 ug/mL Roxithromycintranslation

0.898

SM2-5 ug/mL Streptomycintranslation

-1.322

Tet5-10 ug/mL Tetracyclinetranslation

-0.813

Rif0.2-5ug/mL Rifampicintranscription

0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.977

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.295

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.123

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.298

Clofazimine10-13 ug/mL Clofaziminerespiration

0.072

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.074

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.215

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.095

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.464

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.469

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.111

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.838

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.782

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.386

Nigericin50 uM Nigericinrespiration

-0.697

TRC10-150 ug/mL Triclosanrespiration

0.666

TRZ10-25 ug/mL Thioridazinerespiration

0.125

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.882

menadione6-10 ug/mL Menadionerespiration

0.423

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.384

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.321

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.082

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.757

NRP_1Non-replicating persistence stage 1dosRassociated

-0.132

Amp0.2mg/mL AmpicillincellWall

0.027

Cephalexin20-100 ug/mL CephalexincellWall

0.061

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.829

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.072

EMB10-20 ug/mL EthambutolcellWall

-0.801

Eta12-40 ug/mL EthionamidecellWall

-0.516

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.843

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.255

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.118

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.454

BZA0.12 mg/mL BenzamidearomaticAmides

0.619

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.679

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.301

H2O24 mM hydrogen peroxideDNAdamaging

0.126

Levo10 ug/mL LevofloxacinDNAdamaging

0.416

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.629

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.700

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.114

UVUV-irradiationDNAdamaging

0.200

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.061

Antimycin12.5-50 ug/mL Antimycin A?

0.106

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.369

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.372

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.940

PA8240.2-2 ug/mL PA-824?

-0.271

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.176

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.534

Verapamil50 uM Verapamil?

1.047

mercaptoethanol2 mM 2-Mercaptoethanol?

0.990

methoxatin10-20 ug/mL Methoxatin?